Pfizer faces multi-year headwinds from loss of exclusivity and COVID franchise decline, but management highlights transformative M&A and pipeline optionality. Learn more on PFE stock here.

That sell-off is now hitting a critical level that investors should be watching, not a fundamental level, but a technical one. The technical picture for the Mag 7 is easy to track—there's an ETF for ...

Banks have invested heavily in onboarding new clients, yet legacy KYC records often remain a blind spot. This creates unknown risk exposures that can emerge during audits, regulatory inspections, or ...